C79.82
Secondary malignant neoplasm of genital organs
Clinical Classification Guidelines
Medical Intelligence & Overview
Secondary malignant neoplasm of the genital organs, classified under ICD-10 code C79.82, refers to cancer that originates elsewhere in the body and spreads (metastasizes) to the genital organs. This condition indicates a secondary tumor, which is a result of cancer cells traveling from the primary site to the reproductive organs. It is essential to understand that this diagnosis points to advanced cancer, requiring careful medical evaluation and management. Recognizing the nature of secondary cancers can help in understanding treatment options and prognosis.
Causes & Symptoms
Clinical Causes: Primary cancer in the breast, lung, gastrointestinal tract, or other organs that metastasizes to the genital organs Spread of malignant cells via bloodstream or lymphatic system from their original site Increased risk associated with advanced stage of primary cancers Genetic and environmental factors contributing to aggressive tumor behavior
Key Symptoms: Unusual swelling or lumps in the pelvic or genital region Persistent pain or discomfort in the pelvic area Bleeding or abnormal vaginal discharge in women Urinary or bowel changes such as urgency, frequency, or discomfort General symptoms like weight loss, fatigue, or loss of appetite Asymptomatic in early stages, often discovered through imaging or biopsy
Diagnostic & Treatment
Diagnosis Path: Pelvic ultrasound or MRI to visualize the affected areas CT scans of the abdomen and pelvis to identify metastasis sites Biopsy of the suspected lesion for histopathological examination Blood tests to evaluate overall health and tumor markers Additional scans such as PET to detect further metastases
Treatment Protocols: Systemic therapies such as chemotherapy, targeted therapy, or immunotherapy to address widespread disease Radiation therapy to control localized symptoms or reduce tumor size Hormone therapy in cases where the primary or metastatic tumor responds to hormonal manipulation Surgical intervention may be considered in select cases to remove localized tumors or relieve symptoms Supportive care to manage symptoms, including pain control and palliative treatments Participation in clinical trials exploring novel therapies
Clinical Advice & FAQs
Billing Guidance
Is C79.82 a billable ICD-10 code?
Yes, C79.82 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C79.82?
Clinical documentation must specify the nature of Secondary malignant neoplasm of genital organs and any associated comorbidities for accurate reporting.
Cite this Clinical Reference